fda removes semaglutide from shortage list not allowing compounded The FDA has removed semaglutide injection products (GLP-1) the Cheap, compounded versions of Ozempic,

Genuine medicines available at affordable prices nationwide.

Big news: The World Health Organization (WHO) has released its first global guideline on using GLP-1based medicines to treat obesity redefining obesity as a chronic, relapsing disease that deserves long-term care

At the same time, this isn't a reason to panic or stop the medicine right away

GLP-1 is a key and often life saving form of treatment in patients with diabetes or high heart disease risk

Liraglutide (NN2211) is a long-acting GLP-1 receptor agonist used to treat type 2 diabetes and obesity (Victoza, Saxenda)

The South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) have ramped up a nationwide crackdown on the illegal manufacturing and supply of unregistered weight-loss medicines.